← Open Payments lookup

MICHAEL SIZEMORE: Open Payments

NPI 1184335762 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,222 in 158 payments from 16 companies in 2025. Trend: 2023 $641 · 2024 $1,010 · 2025 $2,222

Food & beverage: $2,151Education: $71
CompanyPaymentsAmount
ABBVIE INC.40$478
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$304
Neurocrine BioSciences, Inc.24$260
Vanda Pharmaceuticals Inc.17$218
Alkermes, Inc.11$193
Otsuka America Pharmaceutical, Inc.13$182
Teva Pharmaceuticals USA, Inc.9$179
Axsome Therapeutics, Inc.6$107
Janssen Pharmaceuticals, Inc3$73
Lundbeck LLC4$61

Products named: VRAYLAR, CAPLYTA, INGREZZA, FANAPT, ARISTADA, REXULTI, Auvelity, ABILIFY ASIMTUFII.

Industry payments across IN — which companies pay providers there.